lactose has been researched along with deferasirox in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brown, M; Niv, Y; Pazgal, I; Perets, TT; Rachmilewitz, E; Stark, P | 1 |
1 trial(s) available for lactose and deferasirox
| Article | Year |
|---|---|
Lactose intolerance is not the cause of gastrointestinal adverse effects in beta thalassemia patients treated with deferasirox.
Topics: Adult; Benzoates; beta-Thalassemia; Breath Tests; Chi-Square Distribution; Deferasirox; Excipients; Female; Gastrointestinal Diseases; Humans; Iron Chelating Agents; Lactose; Lactose Intolerance; Male; Middle Aged; Triazoles; Young Adult | 2014 |
1 other study(ies) available for lactose and deferasirox
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |